Mladen Vidovich, MD
Cardiovascular Disease · Chicago, ILNPI 1952350621
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (56.5%), food and beverage and education — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Medtronic at 38.0% of the total. Reporting peaked in 2022 at $3,208 and has fallen 91.6% since, to $269 in 2025.
Across 92 payments — averaging $130.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- Boston Scientific$3K
- GE HealthCare$855
- Inari Medical, Inc.$751
- Cordis US CORP.$517
- Biotronik Inc.$412
- plus $2K from 16 others
Across 68 payments — averaging $2242.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- CSL Behring$132K
- Janssen Research & Development, LLC$20K
What the payments were for
- Consulting fees$6,79357%
- Travel & lodging$160%
- Food & beverage$5,14443%
- Education$621%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 18 | $4,567 |
| Boston Scientific | 31 | $2,901 |
| GE HealthCare | 1 | $855 |
| Inari Medical, Inc. | 5 | $751 |
| Cordis US CORP. | 2 | $517 |
| Biotronik Inc. | 8 | $412 |
| Abiomed | 6 | $404 |
| Cardiovascular Systems Inc. | 2 | $205 |
| Merit Medical Systems Inc | 1 | $200 |
| Shockwave Medical, Inc | 1 | $189 |
| Abbott | 2 | $154 |
| Kowa Pharmaceuticals America, Inc. | 1 | $132 |
| Philips North America LLC | 2 | $123 |
| Cardinal Health 200 LLC | 2 | $117 |
| Cardiva Medical, Inc. | 1 | $101 |
| Surmodics, Inc. | 3 | $97 |
| Edwards Lifesciences | 1 | $92 |
| Chiesi USA, Inc. | 1 | $62 |
| Cvrx, Inc. | 1 | $59 |
| Teleflex LLC | 1 | $31 |
| Angiodynamics, Inc. | 1 | $24 |
| Terumo Medical Corporation | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL VASCULAR ACCESS$1,500
- VSCAN$855
- FLOWTRIEVER CATHETER, S$595
- CT THROMBECTOMY SYSTEM KIT$595
- AVVIGO Guidance System$351
- Impella$283
- GENERAL - THERAPIES$265
- Coronary Orbital Atherectomy System$205
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$189
- Resolute$184
- Evera$138
- Diamondback Coronary$136
- Livalo$132
- ONYX FRONTIER$118
- GENERAL - STENTS$115
- US Und$104
- Cardiva VASCADE MVP VVCS 6-12F$101
- STINGRAY$100
How this compares
$12,014 in reported general payments places this provider in the 85th percentile of 932 cardiovascular disease providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 37 | $61,943 |
| JardianceEmpagliflozin | 25 | $41,026 |
| EliquisApixaban | 27 | $35,825 |
| OzempicSemaglutide | 12 | $16,754 |
| Praluent PenAlirocumab | 34 | $16,318 |
| FarxigaDapagliflozin Propanediol | 11 | $16,034 |
| RybelsusSemaglutide | 11 | $14,660 |
| Rosuvastatin Calcium | 44 | $1,538 |
| Atorvastatin Calcium | 114 | $1,072 |
| Candesartan Cilexetil | 12 | $1,002 |
| Metoprolol Succinate | 50 | $948 |
| Ezetimibe | 29 | $630 |
| Carvedilol | 70 | $587 |
| Losartan Potassium | 26 | $294 |
| Amlodipine Besylate | 41 | $202 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Chicago
- Sandeep NathanChicago$892K
- Boaz AvitallChicago$366K
- Akhil NarangChicago$363K
- Michael DavidsonChicago$317K
- Jyothy PuthumanaChicago$269K
- Sanjiv ShahChicago$246K
- Raja MutharasanChicago$146K
- Nitasha SarswatChicago$140K
- Evan SteinChicago$121K
- Dan FintelChicago$119K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.